{"id":915810,"date":"2025-12-03T12:18:01","date_gmt":"2025-12-03T17:18:01","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/kuehn-law-encourages-investors-of-twist-bioscience-corporation-to-contact-law-firm-3\/"},"modified":"2025-12-03T12:18:01","modified_gmt":"2025-12-03T17:18:01","slug":"kuehn-law-encourages-investors-of-twist-bioscience-corporation-to-contact-law-firm-3","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/kuehn-law-encourages-investors-of-twist-bioscience-corporation-to-contact-law-firm-3\/","title":{"rendered":"Kuehn Law Encourages Investors of Twist Bioscience Corporation to Contact Law Firm"},"content":{"rendered":"
\n

NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) — Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of\u00a0Twist Bioscience Corporation (NASDAQ: TWST)<\/u><\/strong> breached their fiduciary duties to shareholders.<\/p>\n

According to a federal securities lawsuit, Insiders at Twist Bioscience caused the company to make materially false and\/or misleading statements, as well as failed to disclose material adverse facts, about Twist\u2019s business and operations. Specifically, the Complaint alleges that insiders overstated the commercial viability of Twist\u2019s synthetic DNA manufacturing technology while engaging in accounting fraud and using unsustainable pricing to inflate the company\u2019s true financial condition and prospects.<\/p>\n

If you currently own TWST and purchased prior to December 13, 2019 <\/strong>please contact\u00a0Justin Kuehn, Esq. by email at\u00a0justin@kuehn.law<\/a> or call (833) 672-0814.\u00a0 Kuehn Law pays all case costs and does not charge its investor clients.<\/strong>Shareholders should contact the firm immediately as there may be limited time to enforce your rights.<\/em>\u00a0\u00a0<\/p>\n

\n Why Your Participation Matters:<\/strong>\n <\/p>\n

As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.<\/em>\u2122\u00a0\u00a0<\/p>\n

For additional information, please visit Shareholder Derivative Litigation – Kuehn Law<\/a>.<\/p>\n

Attorney advertising. Prior results do not guarantee similar outcomes.<\/p>\n

Contacts:
Kuehn Law, PLLC
Justin Kuehn, Esq.
53 Hill Street, Suite 605
Southampton, NY 11968
justin@kuehn.law<\/a>
(833) 672-0814<\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) — Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of\u00a0Twist Bioscience Corporation (NASDAQ: TWST) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Twist Bioscience caused the company to make materially false and\/or misleading statements, as well as failed to disclose material adverse facts, about Twist\u2019s business and operations. Specifically, the Complaint alleges that insiders overstated the commercial viability of Twist\u2019s synthetic DNA manufacturing technology while engaging in accounting fraud and using unsustainable pricing to inflate the company\u2019s true financial condition and prospects. If you currently own TWST and purchased prior to December 13, 2019 please contact\u00a0Justin Kuehn, Esq. by email … <\/p>\n

Continue reading “Kuehn Law Encourages Investors of Twist Bioscience Corporation to Contact Law Firm”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-915810","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nKuehn Law Encourages Investors of Twist Bioscience Corporation to Contact Law Firm - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/kuehn-law-encourages-investors-of-twist-bioscience-corporation-to-contact-law-firm-3\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kuehn Law Encourages Investors of Twist Bioscience Corporation to Contact Law Firm - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) — Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of\u00a0Twist Bioscience Corporation (NASDAQ: TWST) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Twist Bioscience caused the company to make materially false and\/or misleading statements, as well as failed to disclose material adverse facts, about Twist\u2019s business and operations. Specifically, the Complaint alleges that insiders overstated the commercial viability of Twist\u2019s synthetic DNA manufacturing technology while engaging in accounting fraud and using unsustainable pricing to inflate the company\u2019s true financial condition and prospects. If you currently own TWST and purchased prior to December 13, 2019 please contact\u00a0Justin Kuehn, Esq. by email … Continue reading "Kuehn Law Encourages Investors of Twist Bioscience Corporation to Contact Law Firm"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/kuehn-law-encourages-investors-of-twist-bioscience-corporation-to-contact-law-firm-3\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-03T17:18:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5NjExNSM3MzA0MTU3IzIyODUyNTU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kuehn-law-encourages-investors-of-twist-bioscience-corporation-to-contact-law-firm-3\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kuehn-law-encourages-investors-of-twist-bioscience-corporation-to-contact-law-firm-3\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Kuehn Law Encourages Investors of Twist Bioscience Corporation to Contact Law Firm\",\"datePublished\":\"2025-12-03T17:18:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kuehn-law-encourages-investors-of-twist-bioscience-corporation-to-contact-law-firm-3\\\/\"},\"wordCount\":236,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kuehn-law-encourages-investors-of-twist-bioscience-corporation-to-contact-law-firm-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5NjExNSM3MzA0MTU3IzIyODUyNTU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kuehn-law-encourages-investors-of-twist-bioscience-corporation-to-contact-law-firm-3\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kuehn-law-encourages-investors-of-twist-bioscience-corporation-to-contact-law-firm-3\\\/\",\"name\":\"Kuehn Law Encourages Investors of Twist Bioscience Corporation to Contact Law Firm - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kuehn-law-encourages-investors-of-twist-bioscience-corporation-to-contact-law-firm-3\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kuehn-law-encourages-investors-of-twist-bioscience-corporation-to-contact-law-firm-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5NjExNSM3MzA0MTU3IzIyODUyNTU=\",\"datePublished\":\"2025-12-03T17:18:01+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kuehn-law-encourages-investors-of-twist-bioscience-corporation-to-contact-law-firm-3\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kuehn-law-encourages-investors-of-twist-bioscience-corporation-to-contact-law-firm-3\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kuehn-law-encourages-investors-of-twist-bioscience-corporation-to-contact-law-firm-3\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5NjExNSM3MzA0MTU3IzIyODUyNTU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5NjExNSM3MzA0MTU3IzIyODUyNTU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kuehn-law-encourages-investors-of-twist-bioscience-corporation-to-contact-law-firm-3\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kuehn Law Encourages Investors of Twist Bioscience Corporation to Contact Law Firm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kuehn Law Encourages Investors of Twist Bioscience Corporation to Contact Law Firm - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/kuehn-law-encourages-investors-of-twist-bioscience-corporation-to-contact-law-firm-3\/","og_locale":"en_US","og_type":"article","og_title":"Kuehn Law Encourages Investors of Twist Bioscience Corporation to Contact Law Firm - Market Newsdesk","og_description":"NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) — Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of\u00a0Twist Bioscience Corporation (NASDAQ: TWST) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Twist Bioscience caused the company to make materially false and\/or misleading statements, as well as failed to disclose material adverse facts, about Twist\u2019s business and operations. Specifically, the Complaint alleges that insiders overstated the commercial viability of Twist\u2019s synthetic DNA manufacturing technology while engaging in accounting fraud and using unsustainable pricing to inflate the company\u2019s true financial condition and prospects. If you currently own TWST and purchased prior to December 13, 2019 please contact\u00a0Justin Kuehn, Esq. by email … Continue reading \"Kuehn Law Encourages Investors of Twist Bioscience Corporation to Contact Law Firm\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/kuehn-law-encourages-investors-of-twist-bioscience-corporation-to-contact-law-firm-3\/","og_site_name":"Market Newsdesk","article_published_time":"2025-12-03T17:18:01+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5NjExNSM3MzA0MTU3IzIyODUyNTU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kuehn-law-encourages-investors-of-twist-bioscience-corporation-to-contact-law-firm-3\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kuehn-law-encourages-investors-of-twist-bioscience-corporation-to-contact-law-firm-3\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Kuehn Law Encourages Investors of Twist Bioscience Corporation to Contact Law Firm","datePublished":"2025-12-03T17:18:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kuehn-law-encourages-investors-of-twist-bioscience-corporation-to-contact-law-firm-3\/"},"wordCount":236,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kuehn-law-encourages-investors-of-twist-bioscience-corporation-to-contact-law-firm-3\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5NjExNSM3MzA0MTU3IzIyODUyNTU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kuehn-law-encourages-investors-of-twist-bioscience-corporation-to-contact-law-firm-3\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/kuehn-law-encourages-investors-of-twist-bioscience-corporation-to-contact-law-firm-3\/","name":"Kuehn Law Encourages Investors of Twist Bioscience Corporation to Contact Law Firm - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kuehn-law-encourages-investors-of-twist-bioscience-corporation-to-contact-law-firm-3\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kuehn-law-encourages-investors-of-twist-bioscience-corporation-to-contact-law-firm-3\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5NjExNSM3MzA0MTU3IzIyODUyNTU=","datePublished":"2025-12-03T17:18:01+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kuehn-law-encourages-investors-of-twist-bioscience-corporation-to-contact-law-firm-3\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/kuehn-law-encourages-investors-of-twist-bioscience-corporation-to-contact-law-firm-3\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kuehn-law-encourages-investors-of-twist-bioscience-corporation-to-contact-law-firm-3\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5NjExNSM3MzA0MTU3IzIyODUyNTU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5NjExNSM3MzA0MTU3IzIyODUyNTU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kuehn-law-encourages-investors-of-twist-bioscience-corporation-to-contact-law-firm-3\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Kuehn Law Encourages Investors of Twist Bioscience Corporation to Contact Law Firm"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/915810","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=915810"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/915810\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=915810"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=915810"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=915810"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}